Dalzanemdor
id:
dalzanemdor-189-2777636
title:
Dalzanemdor
text:
Dalzanemdor is experimental drug being investigated for the treatment of neurological disorders and cognitive impairment. It acts as a positive allosteric modulator of the NMDA receptor, whose activity is essential for learning, memory, and cognition. Dalzanemdor is an analogue of the neurosteroid 24S-hydroxycholesterol. As of 2022, dalzanemdor is in Phase II clinical trials for Alzheimer's disease, Parkinson's disease, and Huntington's disease.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dalzanemdor
date created:
2022-07-13T00:55:15Z
date modified:
2024-09-09T03:56:35Z
main entity:
{"identifier":"Q113130261","url":"https://www.wikidata.org/entity/Q113130261"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c4/Dalzanemdor.svg","width":850,"height":425}
fields total:
13
integrity:
16